Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05000047 · ClinicalTrials.gov registry record
Clinical Performance Evaluation of 3D Ear Canal Scanning Technology
A clinical trial, sponsored by Sonova.
- Completed
- Registry status
- 30
- Enrollment target
NCT05000047: Completed study, sponsored by Sonova.
NCT05000047 is a clinical trial that has completed, run by Sonova. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05000047 has completed, sponsored by Sonova.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Study participants will undergo ear canal impressions in a standard of care protocol utilizing two methodologies: 3D ear scanning using a commercially-available ear scanning device, and conventional silicone impression material. The elapsed time of each procedure will be captured for each participant, and the average duration of the two methodologies will be compared.
Primary Outcome
The total time in minutes, required for sub-investigators to complete each impression methodology on each participant, according to a standard of care procedure . For the silicone impressions, time was started after otoscopy and cerumen management of both ears, and just before prepping and placing the otoblocks. The timer stopped after the audiologist was satisfied with both ear impressions and placed them in box. For the ear scan, time was started after otoscopy of both ears, and just before pr
Interventions
- DEVICE 3D ear scanner
- OTHER Conventional silicon ear impressions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-05-17 |
| Est. Completion | 2021-07-15 |
What the finished NCT05000047 record still lists
NCT05000047 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which 3D ear scanner is the first listed.
NCT05000047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05000047 about?
NCT05000047 is a clinical study titled "Clinical Performance Evaluation of 3D Ear Canal Scanning Technology". Study participants will undergo ear canal impressions in a standard of care protocol utilizing two methodologies: 3D ear scanning using a commercially-available ear scanning device, and conventional silicone impression material. The elapsed time of each procedure will be captured for each participan...
What is the current status of trial NCT05000047?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-05-17. Estimated completion is 2021-07-15.
What interventions are being tested in trial NCT05000047?
The interventions under investigation include: 3D ear scanner (DEVICE), Conventional silicon ear impressions (OTHER).
Who is sponsoring clinical trial NCT05000047?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI